Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: A phase III trial (E2995)

Peter L. Greenberg, Sandra J. Lee, Ranjana Advani, Martin S. Tallman, Branimir I. Sikic, Louis Letendre, Kathleen Dugan, Bert Lum, David L. Chin, Gordon Dewald, Elisabeth Paietta, John M. Bennett, Jacob M. Rowe

Research output: Contribution to journalArticlepeer-review

198 Scopus citations

Fingerprint

Dive into the research topics of 'Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: A phase III trial (E2995)'. Together they form a unique fingerprint.

Medicine & Life Sciences